The lancet. Diabetes & endocrinology
-
Lancet Diabetes Endocrinol · Jan 2020
Randomized Controlled TrialUse of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
Continuous glucose monitoring, either real-time (personal) or retrospective (professional mode), can identify day-to-day glucose profiles to guide management decisions for people with type 2 diabetes. We aimed to examine the effects of professional-mode flash glucose monitoring, done at 3-month intervals, in adults with type 2 diabetes in general practice. ⋯ National Health and Medical Research Council of Australia, Sanofi Australia, and Abbott Diabetes Care.